)
Edge15 May 2026
TOMRA: Closing the Loop
The story of TOMRA: from reverse vending machine pioneer to global technology for deposit systems, recycling, and resource optimization.
Artelo Biosciences
Artelo Biosciences (ARTL) investor relations material
Artelo Biosciences Registration filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Registration filing summary14 May, 2026
Management team and governance
Principal executive officers include the President/CEO, CFO, and several directors, all of whom have signed the registration statement as of May 14, 2026.
The company is incorporated in Nevada and operates from Solana Beach, CA.
Indemnification agreements are in place for directors and officers, providing maximum protection allowed by Nevada law, and the company maintains insurance for these individuals.
Offering details and pricing
The registration statement is filed on Form S-3, allowing for the offer and sale of securities from time to time after effectiveness.
The offering may include various types of securities, including debt securities, as detailed in the filed Indenture.
Estimated SEC registration fee is $788.05, with additional fees for accounting, legal, and other services to be determined based on the size and type of offering.
Unsold securities from a previous registration statement will have their registration fees carried forward.
Underwriters and syndicate
The form of underwriting agreement is listed as an exhibit, to be filed by amendment or incorporated by reference.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Artelo Biosciences
- Q1 2026 net loss reached $3.0M; cash at $10.3M after $10M financing, but going concern risk remains.ARTL
Q1 202615 May 2026 - Advancing novel lipid signaling drugs with strong clinical data and large market potential.ARTLCorporate presentation14 May 2026
- Shareholders will vote on director elections, executive pay, enhanced governance, and updated executive agreements.ARTLProxy filing6 May 2026
- Biopharma aims to raise up to $75M for novel therapies in oncology and neurology via shelf offering.ARTLRegistration filing4 May 2026
- Biopharma registers 9.8M shares for resale, targeting unmet needs but facing dilution risks.ARTLRegistration filing7 Apr 2026
- Equity line agreement enables up to $50M in funding but poses dilution and market risks.ARTLRegistration filing24 Mar 2026
- Biopharma seeks $10.9M via equity/warrants to fund clinical pipeline amid Nasdaq compliance risks.ARTLRegistration filing24 Mar 2026
- Lead programs show strong clinical progress in cancer anorexia, neuropathy, and anxiety.ARTLCorporate presentation24 Mar 2026
- Biopharma seeks up to $10.8M via share/warrant offering to fund clinical pipeline, with dilution risk.ARTLRegistration filing23 Mar 2026
Next Artelo Biosciences earnings date
Q2 202612 Aug, 2026
Artelo Biosciences
Next Artelo Biosciences earnings date
Q2 202612 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage